Synapticure, a Chicago, IL-based virtual care company dedicated to improving access and outcomes for patients and caregivers living with Alzheimer’s and related dementias, Parkinson’s, and other neurodegenerative diseases, raised $25M in Series A funding.
The round was led by B Capital, with participation from CommonSpirit Health, CVS Health Ventures, RA Capital Management, and Nexus NeuroTech Ventures, as well as existing investors Google Ventures, Optum Ventures, and Rock Health Capital.
The company intends to use the funds to:
- Expand partnerships with leading healthcare providers and payers, building on key collaborations announced earlier this year, including being selected as a CMS GUIDE (Guiding an Improved Dementia Experience) provider in all 50 states.
- Invest in its proprietary technology platform, further deploying AI-enabled analytics and clinical research to accelerate diagnosis and treatment, monitor patients remotely, ensure 24/7 support, and implement solutions that ease the burden on families managing the complex needs of neurodegenerative conditions.
- Fast-track clinical research and expand patient access to emerging treatments and clinical trials.
- Scale its national medical group by bringing on additional providers to meet increasing demand while continuing to deliver personalized care, and introduce new offerings enabled by relationships with patient advocacy organizations.
Founded by Sandra Abrevaya, Brian Wallach, Peter Wallach, Jason Langheier, and Jonathan Hirsch, Synapticure is a patient- and caregiver-founded virtual care provider offering instant access to expert neurologists, treatments and trials, wraparound care coordination, and behavioral health support in all 50 states. Partnering with providers and health plans, including CMS’ new GUIDE dementia care model, the company is dedicated to transforming the lives of millions of individuals and their families living with neurodegenerative diseases like Alzheimer’s, Parkinson’s and ALS.
FinSMEs
20/11/2024